HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 208 filers reported holding HAEMONETICS CORP in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $417,000 | -58.7% | 6,591 | -65.4% | 0.00% | -33.3% |
| Q4 2021 | $1,010,000 | +221.7% | 19,048 | +304.7% | 0.00% | +200.0% |
| Q2 2021 | $314,000 | -86.6% | 4,707 | -77.7% | 0.00% | -92.9% |
| Q1 2021 | $2,339,000 | +107.4% | 21,072 | +121.9% | 0.01% | +75.0% |
| Q4 2020 | $1,128,000 | -53.7% | 9,498 | -65.9% | 0.01% | -75.8% |
| Q3 2020 | $2,434,000 | -72.1% | 27,893 | -71.4% | 0.03% | -76.6% |
| Q2 2020 | $8,723,000 | +110.3% | 97,393 | +134.0% | 0.14% | +33.0% |
| Q1 2020 | $4,148,000 | +103.7% | 41,625 | +134.9% | 0.11% | +783.3% |
| Q4 2019 | $2,036,000 | -18.3% | 17,721 | -14.4% | 0.01% | -50.0% |
| Q2 2019 | $2,492,000 | +1127.6% | 20,705 | +920.5% | 0.02% | +1100.0% |
| Q4 2018 | $203,000 | -95.5% | 2,029 | -96.0% | 0.00% | -96.7% |
| Q2 2018 | $4,515,000 | +2102.4% | 50,342 | +1327.7% | 0.06% | +1400.0% |
| Q4 2017 | $205,000 | -69.0% | 3,526 | -76.1% | 0.00% | -69.2% |
| Q3 2017 | $662,000 | – | 14,754 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |